My watch list  

Gambro is a global medical technology company and a leader in developing, manufacturing and supplying products, therapies and services for In-center Care and Self Care Hemodialysis, Peritoneal Dialysis, Renal Intensive Care and Hepatic Care.

For decades, Gambro has led the market in renal care development and has been first to market with many groundbreaking innovations. Gambro is the only clinic-independent company and by designing and delivering complete solutions to dialysis clinics and intensive care units, Gambro offers not just improved treatment quality, but also improved efficiency.

More about Gambro
  • News

    New structure to strengthen growth

    The Gambro Group will develop into three independent companies. Gambro Renal Products will become the new Gambro. Gambro Healthcare and Gambro BCT will gradually become independent companies with formal Boards of Directors and independent governance processes. When the legal reorganization ... more

    Gambro and DaVita reach agreement on Amended Alliance and Product Supply Agreement

    Gambro AB, Gambro Renal Products, Inc. and DaVita Inc. have agreed to an amended and restated Alliance and Product Supply Agreement. This amendment effectively revokes the termination notice which was provided by DaVita in May primarily as a result of Gambro Renal Products' inability to sup ... more

    Jan Bruneheim new President and CEO for Gambro

    Sören Mellstig, Gambro's current President and CEO, and Gambro's new Board of Directors have agreed on that Sören Mellstig will leave his position. Jan Bruneheim, 52, has been appointed new President and CEO for Gambro. Jan Bruneheim will take over the position August 2, 2006. Sören Mells ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE